Evidence map›Paper›PMID 36927149›Full record

ArticleHuman gene therapy2023

Assessment of Pre-Clinical Liver Models Based on Their Ability to Predict the Liver-Tropism of Adeno-Associated Virus Vectors.

Adrian Westhaus, Marti Cabanes-Creus, Kimberley L Dilworth, Erhua Zhu, David Salas Gómez, Renina G Navarro, Anais K Amaya, Suzanne Scott, Magdalena Kwiatek, Alexandra L McCorkindale and 17 more

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Human gene therapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
7.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Tailoring capsid-directed evolution technology for improved AAV-mediated CAR-T generation.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Article
  6. Article
  7. Article
  8. Targeted Gene Insertion: The Cutting Edge of CRISPR Drug Development with Hemophilia as a Highlight.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 2024
    Review
  9. Article
  10. Development of CNS tropic AAV1-like variants with reduced liver-targeting following systemic administration in mice.Molecular therapy : the journal of the American Society of Gene Therapy · 2024
    Article
  11. Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

  • Erratum issued
    2023
5 · Who and what money

Authors and funding

27 authors at 10 institutions in 5 countries.

Adrian WesthausTranslational Vectorology Research Unit, Children's Medical Research Institute, Faculty of Medicine and Health, The University of Sydney, Westmead, Australia.ORCID 0000-0001-6439-4326
Marti Cabanes-CreusTranslational Vectorology Research Unit, Children's Medical Research Institute, Faculty of Medicine and Health, The University of Sydney, Westmead, Australia.
Kimberley L DilworthTranslational Vectorology Research Unit, Children's Medical Research Institute, Faculty of Medicine and Health, The University of Sydney, Westmead, Australia.
Erhua ZhuGene Therapy Research Unit, Children's Medical Research Institute and Sydney Children's Hospitals Network, Faculty of Medicine and Health, The University of Sydney, Westmead, Australia.
David Salas GómezGene Therapy and Regulation of Gene Expression Department, IdiSNA, Instituto de Investigación Sanitaria de Navarra, Universidad de Navarra, CIMA, Pamplona, Spain.
Renina G NavarroTranslational Vectorology Research Unit, Children's Medical Research Institute, Faculty of Medicine and Health, The University of Sydney, Westmead, Australia.
Anais K AmayaGene Therapy Research Unit, Children's Medical Research Institute and Sydney Children's Hospitals Network, Faculty of Medicine and Health, The University of Sydney, Westmead, Australia.ORCID 0000-0002-8396-2226
Suzanne ScottTranslational Vectorology Research Unit, Children's Medical Research Institute, Faculty of Medicine and Health, The University of Sydney, Westmead, Australia.
Magdalena KwiatekMilitary Institute of Hygiene and Epidemiology, The Biological Threats Identification and Countermeasure Centre, Puławy, Poland.
Alexandra L McCorkindaleInventia Life Science Pty Ltd., Sydney, Australia.
Tara E HaymanInventia Life Science Pty Ltd., Sydney, Australia.
Silke FrahmStem Cell Technology Platform, Max Delbrück Centrum for Molecular Medicine, Berlin, Germany.
Dany P PerocheauGenetics and Genomic Medicine Department, Great Ormond Street Institute of Child Health, University College London, London, United Kingdom.
Bang Manh TranDepartment of Infectious Diseases, Melbourne Medical School, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Elizabeth VincanDepartment of Infectious Diseases, Melbourne Medical School, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Sharon L WongMolecular and Integrative Cystic Fibrosis (miCF) Research Centre, University of New South Wales and Sydney Children's Hospital, Sydney, Australia.
Shafagh A WatersMolecular and Integrative Cystic Fibrosis (miCF) Research Centre, University of New South Wales and Sydney Children's Hospital, Sydney, Australia.
Georgina E RiddioughDepartment of Infectious Diseases, Melbourne Medical School, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Marcos V PeriniDepartment of Surgery, Austin Health Precinct, The University of Melbourne, Austin Health, Heidelberg, Australia.
Laurence O W WilsonAustralian e-Health Research Centre, Commonwealth Scientific and Industrial Research Organisation, Sydney, Australia.
Julien BaruteauGenetics and Genomic Medicine Department, Great Ormond Street Institute of Child Health, University College London, London, United Kingdom.
Sebastian DieckeStem Cell Technology Platform, Max Delbrück Centrum for Molecular Medicine, Berlin, Germany.
Gloria González-AseguinolazaGene Therapy and Regulation of Gene Expression Department, IdiSNA, Instituto de Investigación Sanitaria de Navarra, Universidad de Navarra, CIMA, Pamplona, Spain.ORCID 0000-0002-1600-4562
Giorgia SantilliGreat Ormond Street Institute of Child Health, University College London, London, United Kingdom.ORCID 0000-0003-1776-1984
Adrian J ThrasherGreat Ormond Street Institute of Child Health, University College London, London, United Kingdom.ORCID 0000-0002-6097-6115
Ian E AlexanderGene Therapy Research Unit, Children's Medical Research Institute and Sydney Children's Hospitals Network, Faculty of Medicine and Health, The University of Sydney, Westmead, Australia.
Leszek LisowskiTranslational Vectorology Research Unit, Children's Medical Research Institute, Faculty of Medicine and Health, The University of Sydney, Westmead, Australia.ORCID 0000-0002-4772-8651
The University of Sydney · AUGreat Ormond Street Hospital · GBCommonwealth Scientific and Industrial Research Organisation · AUMax Delbrück Center · DENavarre Institute of Health Research · ESThe University of Melbourne · AUUNSW Sydney · AUAustin Health · AUThe Royal Melbourne Hospital · AUWojskowy Instytut Higieny i Epidemiologii · PL

Funding

Department of HealthMedical Research Council MR/T008024/1Wellcome Trust 217112/Z/19/Z
6 · The paper itself

Abstract

The liver is a prime target for

Indexed as

DependovirusLiverCapsid ProteinsGenetic TherapyGenetic VectorsHepatocytesHumansTropismCapsid ProteinsAAVhepatocyteliver gene therapynonhuman primatexenograft model

Identifiers

PMID36927149
PMCPMC10150726
OpenAlexW4327581102

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.